GES-13, a β-Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

GES-13 beta-lactamase, a novel GES variant possessing Lys-104 and Asn-170, was identified in Pseudomonas aeruginosa. bla(GES-13) was the single gene cassette of a class 1 integron probably located in the chromosome. GES-13 efficiently hydrolyzed broad-spectrum cephalosporins and aztreonam. Imipenem was a potent inhibitor of GES-13 but was not hydrolyzed at measurable rates.

Knowledge Graph

Similar Paper

GES-13, a β-Lactamase Variant Possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2010.0
GES-11, a Novel Integron-Associated GES Variant in Acinetobacter baumannii
Antimicrobial Agents and Chemotherapy 2009.0
Nosocomial Spread of Colistin-Only-Sensitive Sequence Type 235 Pseudomonas aeruginosa Isolates Producing the Extended-Spectrum β-Lactamases GES-1 and GES-5 in Spain
Antimicrobial Agents and Chemotherapy 2009.0
Characterization of the New Metallo-β-Lactamase VIM-13 and Its Integron-Borne Gene from a Pseudomonas aeruginosa Clinical Isolate in Spain
Antimicrobial Agents and Chemotherapy 2008.0
Extended-Spectrum Cephalosporinases in Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy 2009.0
Metallo-β-Lactamase Gene bla <sub>IMP-15</sub> in a Class 1 Integron, In 95 , from Pseudomonas aeruginosa Clinical Isolates from a Hospital in Mexico
Antimicrobial Agents and Chemotherapy 2008.0
Diversity of β-Lactamases Produced by Ceftazidime-Resistant Pseudomonas aeruginosa Isolates Causing Bloodstream Infections in Brazil
Antimicrobial Agents and Chemotherapy 2009.0
Detection of the Novel Extended-Spectrum β-Lactamase OXA-161 from a Plasmid-Located Integron inPseudomonas aeruginosaClinical Isolates from Spain
Antimicrobial Agents and Chemotherapy 2009.0
Comparative Biochemical and Computational Study of the Role of Naturally Occurring Mutations at Ambler Positions 104 and 170 in GES β-Lactamases
Antimicrobial Agents and Chemotherapy 2010.0
Full Resistance and Decreased Susceptibility to Carbapenems in IMP-13-Producing Pseudomonas aeruginosa Isolates from an Outbreak
Antimicrobial Agents and Chemotherapy 2010.0